An open-label study to determine the pharmacokinetic profiles of amoxicillin and clavulanate in adolescent patients weighing at least 40 kg and no more than 16 years of age receiving Augmentin XR (amoxicillin 2000 mg/clavulanate 125 mg) orally twice daily for 10 days.

Trial Profile

An open-label study to determine the pharmacokinetic profiles of amoxicillin and clavulanate in adolescent patients weighing at least 40 kg and no more than 16 years of age receiving Augmentin XR (amoxicillin 2000 mg/clavulanate 125 mg) orally twice daily for 10 days.

Completed
Phase of Trial: Phase I

Latest Information Update: 03 Aug 2017

At a glance

  • Drugs Amoxicillin/clavulanic acid (Primary)
  • Indications Acute sinusitis; Bacterial infections
  • Focus Pharmacokinetics
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 23 Feb 2010 Actual end date (Apr 2007) added as reported by ClinicalTrials.gov.
    • 17 Aug 2007 Status changed from recruiting to completed
    • 28 Sep 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top